Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06621979 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Evaluation of the Fundoplicature of the Excluded Stomach Post Omega Bypass

Study acronym: FEE-RGOIC
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv4
  2. Trial status: Not Yet Recruiting to Recruiting
    • Primary and study completion dates: Sep 30, 2025 to Dec 31, 2026
    • Start date changed from estimate of Apr 2025 to Nov 24, 2025
    • Site details revised
    v3
  3. Start date: Oct 2024 to Apr 2025
    • Collaborators expanded, about 2 words
    v2
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate the efficacy of fundoplication with stomach excluded in the suppression of disabling gastroesophageal reflux requiring surgery in patients who have undergone one anastomosis gastric bypass, with complete objective evaluation of reflux.
Trial Details
NCT Number NCT06621979
Lead Sponsor GCS Ramsay Santé pour l'Enseignement et la Recherche
Collaborators: Euraxi Pharma
Conditions
(from sponsor)		 Bypass, Gastric
Enrollment 17 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov